6887 — Sunshine Lake Pharma Co Cashflow Statement
0.000.00%
Last trade - 00:00- HK$32.96bn
- HK$38.00bn
- CNY4.02bn
Annual cashflow statement for Sunshine Lake Pharma Co, fiscal year end - December 31st, CNY millions except per share, conversion factor applied.
2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final |
| Net Income/Starting Line | -1,480 | 1,385 | 141 |
| Depreciation | |||
| Amortisation | |||
| Non-Cash Items | 2,040 | 982 | 485 |
| Unusual Items | |||
| Equity in Net Earnings/Losses | |||
| Other Non-Cash Items | |||
| Changes in Working Capital | 203 | -1,469 | -544 |
| Change in Accounts Receivable | |||
| Change in Inventories | |||
| Change in Payable / Accrued Expenses | |||
| Other Operating Cash Flow | |||
| Cash from Operating Activities | 1,161 | 1,318 | 501 |
| Capital Expenditures | -1,017 | -535 | -1,225 |
| Purchase of Fixed Assets | |||
| Purchase / Acquisition of Intangibles | |||
| Other Investing Cash Flow Items | -92.4 | -1,148 | 1,255 |
| Sale of Fixed Assets | |||
| Sale/Maturity of Investment | |||
| Purchase of Investments | |||
| Other Investing Cash Flow | |||
| Cash from Investing Activities | -1,110 | -1,683 | 29.8 |
| Financing Cash Flow Items | -2,207 | 2,000 | -145 |
| Other Financing Cash Flow | |||
| Net Issuance / Retirement of Stock | |||
| Net Issuance / Retirement of Debt | |||
| Cash from Financing Activities | -314 | 1,314 | -971 |
| Foreign Exchange Effects | |||
| Beginning Cash Balance | |||
| Ending Cash Balance | |||
| Net Change in Cash | -261 | 949 | -439 |